Literature DB >> 22180759

Severe hypomagnesaemia due to lansoprazole.

Chit Hmu1, Probal Moulik, Andrew Macleod.   

Abstract

A 71-year-old woman, who had been taking lansoprazole for 18 months for dyspepsia, presented with vomiting, thought to be due to gallstones, and was found to have severe hypomagnesaemia. She was treated with intravenous and then oral magnesium, and discharged, but was soon readmitted with symptoms due to hypomagnesaemia, and again treated with magnesium supplementation. No other recognised cause for hypomagnesaemia was found. Because of recent reports of hypomagnesaemia due to other proton pump inhibitors, lansoprazole was changed to ranitidine. Her symptoms resolved and the serum magnesium returned to normal. Oral magnesium supplementation was stopped with no return of symptoms or hypomagnesaemia. Such an association must be borne in mind with suggestive symptoms in patients on long term proton pump inhibitors; their cessation or change to H(2) receptor antagonists is likely to correct the situation rapidly.

Entities:  

Year:  2009        PMID: 22180759      PMCID: PMC3029321          DOI: 10.1136/bcr.07.2009.2098

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.

Authors:  Martin Epstein; Shaun McGrath; Florence Law
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

2.  Omeprazole and refractory hypomagnesaemia.

Authors:  N Shabajee; E J Lamb; I Sturgess; R W Sumathipala
Journal:  BMJ       Date:  2008-07-10

3.  Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.

Authors:  David C Metz; Mark B Sostek; Philippe Ruszniewski; Christopher E Forsmark; John Monyak; Joseph R Pisegna
Journal:  Am J Gastroenterol       Date:  2007-08-31       Impact factor: 10.864

4.  [Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?].

Authors:  M François; N Lévy-Bohbot; J Caron; V Durlach
Journal:  Ann Endocrinol (Paris)       Date:  2008-07-09       Impact factor: 2.478

5.  Severe hypomagnesaemia in long-term users of proton-pump inhibitors.

Authors:  T Cundy; A Dissanayake
Journal:  Clin Endocrinol (Oxf)       Date:  2008-01-23       Impact factor: 3.478

  5 in total
  4 in total

1.  Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.

Authors:  Ioannis Koulouridis; Mansour Alfayez; Hocine Tighiouart; Nicolaos E Madias; David M Kent; Jessica K Paulus; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2013-05-10       Impact factor: 8.860

2.  Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?

Authors:  Yasuhito Takeda; Hisashi Doyama; Kunihiro Tsuji; Shinya Yamada; Kenichi Takemura
Journal:  BMJ Open Gastroenterol       Date:  2015-02-06

Review 3.  Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors.

Authors:  Simone Janett; Pietro Camozzi; Gabriëlla G A M Peeters; Sebastiano A G Lava; Giacomo D Simonetti; Barbara Goeggel Simonetti; Mario G Bianchetti; Gregorio P Milani
Journal:  Gastroenterol Res Pract       Date:  2015-05-04       Impact factor: 2.260

4.  Posaconazole and isavuconazole induced hypomagnesaemia.

Authors:  John Burston; Mark Robertson; Sebastian van Hal; Angie N Pinto
Journal:  Med Mycol Case Rep       Date:  2018-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.